Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
Saved in:
| Title: | Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study. |
|---|---|
| Authors: | Johannes CB; RTI Health Solutions, Waltham, MA, USA., Ziemiecki R; RTI Health Solutions, Research Triangle Park, NC, USA., Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Ebert N; Charité-Universitätsmedizin Berlin, Berlin, Germany., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Thomsen RW; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Baak BN; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., García-Sempere A; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Kanegae H; Genki Plaza Medical Centre for Health Care, Tokyo, Japan., Coleman CI; University of Connecticut School of Pharmacy, Storrs, CT, USA.; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA., Walsh M; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada., Andersen IT; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Rodríguez Bernal C; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Robles Cabaniñas C; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Christiansen CF; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Farjat AE; Bayer AG, Berlin, Germany., Gay A; Bayer AG, Berlin, Germany., Gee P; National Kidney Foundation Advocacy, Richmond, VA, USA., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Hurtado I; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain., Kashihara N; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan., Kristensen FPB; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Liu F; Bayer AG, Berlin, Germany., Okami S; Bayer AG, Berlin, Germany., Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Penning-van Beest FJA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Yamashita S; Bayer AG, Berlin, Germany., Yano Y; NCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan., Layton JB; RTI Health Solutions, Research Triangle Park, NC, USA., Vizcaya D; Bayer AG, Berlin, Germany., Oberprieler NG; Bayer AG, Berlin, Germany. niki.oberprieler@bayer.com.; Bayer AS, Oslo, Norway. niki.oberprieler@bayer.com. |
| Source: | Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2025 Feb; Vol. 16 (2), pp. 205-226. Date of Electronic Publication: 2024 Dec 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1869-6953 (Print) Linking ISSN: 18696961 NLM ISO Abbreviation: Diabetes Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39688776 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Johannes+CB%22">Johannes CB</searchLink>; RTI Health Solutions, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ziemiecki+R%22">Ziemiecki R</searchLink>; RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pladevall-Vila+M%22">Pladevall-Vila M</searchLink>; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Ebert+N%22">Ebert N</searchLink>; Charité-Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Kovesdy+CP%22">Kovesdy CP</searchLink>; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Thomsen+RW%22">Thomsen RW</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Baak+BN%22">Baak BN</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22García-Sempere+A%22">García-Sempere A</searchLink>; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Kanegae+H%22">Kanegae H</searchLink>; Genki Plaza Medical Centre for Health Care, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Coleman+CI%22">Coleman CI</searchLink>; University of Connecticut School of Pharmacy, Storrs, CT, USA.; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+M%22">Walsh M</searchLink>; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Andersen+IT%22">Andersen IT</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Bernal+C%22">Rodríguez Bernal C</searchLink>; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Robles+Cabaniñas+C%22">Robles Cabaniñas C</searchLink>; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Christiansen+CF%22">Christiansen CF</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Farjat+AE%22">Farjat AE</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gay+A%22">Gay A</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Gee+P%22">Gee P</searchLink>; National Kidney Foundation Advocacy, Richmond, VA, USA.<br /><searchLink fieldCode="AU" term="%22Herings+RMC%22">Herings RMC</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hurtado+I%22">Hurtado I</searchLink>; Valencia Health System Integrated Database, Health Services Research Unit, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Kashihara+N%22">Kashihara N</searchLink>; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.<br /><searchLink fieldCode="AU" term="%22Kristensen+FPB%22">Kristensen FPB</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.<br /><searchLink fieldCode="AU" term="%22Liu+F%22">Liu F</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Okami+S%22">Okami S</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Overbeek+JA%22">Overbeek JA</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Penning-van+Beest+FJA%22">Penning-van Beest FJA</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Yamashita+S%22">Yamashita S</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Yano+Y%22">Yano Y</searchLink>; NCD Epidemiology Research Center, Shiga University of Medical Science, Shiga, Japan.; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Layton+JB%22">Layton JB</searchLink>; RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Vizcaya+D%22">Vizcaya D</searchLink>; Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Oberprieler+NG%22">Oberprieler NG</searchLink>; Bayer AG, Berlin, Germany. niki.oberprieler@bayer.com.; Bayer AS, Oslo, Norway. niki.oberprieler@bayer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101539025%22">Diabetes therapy : research, treatment and education of diabetes and related disorders</searchLink> [Diabetes Ther] 2025 Feb; Vol. 16 (2), pp. 205-226. <i>Date of Electronic Publication: </i>2024 Dec 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Healthcare%22">Springer Healthcare </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101539025 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1869-6953 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218696961%22">18696961 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Ther <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39688776 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s13300-024-01671-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 205 Titles: – TitleFull: Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Johannes CB – PersonEntity: Name: NameFull: Ziemiecki R – PersonEntity: Name: NameFull: Pladevall-Vila M – PersonEntity: Name: NameFull: Ebert N – PersonEntity: Name: NameFull: Kovesdy CP – PersonEntity: Name: NameFull: Thomsen RW – PersonEntity: Name: NameFull: Baak BN – PersonEntity: Name: NameFull: García-Sempere A – PersonEntity: Name: NameFull: Kanegae H – PersonEntity: Name: NameFull: Coleman CI – PersonEntity: Name: NameFull: Walsh M – PersonEntity: Name: NameFull: Andersen IT – PersonEntity: Name: NameFull: Rodríguez Bernal C – PersonEntity: Name: NameFull: Robles Cabaniñas C – PersonEntity: Name: NameFull: Christiansen CF – PersonEntity: Name: NameFull: Farjat AE – PersonEntity: Name: NameFull: Gay A – PersonEntity: Name: NameFull: Gee P – PersonEntity: Name: NameFull: Herings RMC – PersonEntity: Name: NameFull: Hurtado I – PersonEntity: Name: NameFull: Kashihara N – PersonEntity: Name: NameFull: Kristensen FPB – PersonEntity: Name: NameFull: Liu F – PersonEntity: Name: NameFull: Okami S – PersonEntity: Name: NameFull: Overbeek JA – PersonEntity: Name: NameFull: Penning-van Beest FJA – PersonEntity: Name: NameFull: Yamashita S – PersonEntity: Name: NameFull: Yano Y – PersonEntity: Name: NameFull: Layton JB – PersonEntity: Name: NameFull: Vizcaya D – PersonEntity: Name: NameFull: Oberprieler NG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1869-6953 Numbering: – Type: volume Value: 16 – Type: issue Value: 2 Titles: – TitleFull: Diabetes therapy : research, treatment and education of diabetes and related disorders Type: main |
| ResultId | 1 |
